Management of chronic critical limb ischemia

Cardiology Clinics

Volumn 20, Issue 4, 2002, Pages 535-545

  Rajagopalan, Sanjay ^a   Michael Grossman, P ^a  

^a Women's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOGENIC FACTOR; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; DIPYRIDAMOLE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTANOID; VASOACTIVE AGENT;

ALGORITHM; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DISEASE PREDISPOSITION; ECONOMIC ASPECT; HUMAN; INCIDENCE; LIMB ISCHEMIA; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE;

ALGORITHMS; AMPUTATION; CHRONIC DISEASE; GRAFT OCCLUSION, VASCULAR; HUMANS; ISCHEMIA; LEG; QUALITY OF LIFE; RISK FACTORS; VASCULAR SURGICAL PROCEDURES;

EID: 0036851776     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(02)00090-5     Document Type: Review

References (30)

1. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg 1997;26:517-38.
2. Second European Consensus Document on chronic critical leg ischemia. Circulation 1991;84:IV: 1-26.
3. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6.
4. Lepantalo M, Matzke S. Outcome of unreconstructed chronic critical leg ischaemia. Eur J Vasc Endovasc Surg 1996;11:153-7.
5. Eneroth M, Apelqvist J, Troeng T, et al. Operations, total hospital stay and costs of critical leg ischemia: A population-based longitudinal outcome study of 321 patients. Acta Orthop Scand 1996;67: 459-65.
6. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002;360:7-22.
7. Edmondson RA, Cohen AT, Das SK, Wagner MB, Kakkar VV. Low molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting. Lancet 1994;344:914-8.
8. Management of Peripheral Arterial Disease (PAD). Transatlantic inter-society consensus. J Vasc Surg 2000;31:S168-280.
9. Dormandy JA, Loh A. Critical Limb Ischemia. London: Arnold; 1996.
10. Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF 165 after intramuscular gene transfer promotes collateral vessel developement in patients with critical limb ischemia. Circulation 1998;97:1114-23.
11. Comerota A, Throm R, Miller K, et al. Naked plasmid DNA encoding fibroblast growth factor type I for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a phase I trial. Journal of Vascular Surgery 2002; 35:930-6.
12. Rajagopalan S, Lederman RJ, Annex BN. Angiogenic therapy for critical limb ischemia: From concept to the design of clinical trials. Cardiac Vasc Regeneration 2000;1:114-25.
13. Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease [published erratum appears in Radiology 1997;205:584]. Radiology 1997;204:87-96.
14. Tetteroo E, van der Graaf Y, Bosch JL, et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet 1998;351:1153-9.
15. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. J Vasc Surg 2000;31:S1-296.
16. Wolf GL, Wilson SE, Cross AP, et al. Surgery or balloon angioplasty for peripheral vascular disease: A randomized clinical trial. Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199. J Vasc Interv Radiol 1993;4:639-48.
17. Jeans WD, Armstrong S, Cole SE, et al. Fate of patients undergoing transluminal angioplasty for lower-limb ischemia. Radiology 1990;177: 559-64.
18. Wagner HJ, Rager G. [Infrapopliteal Angioplasty: A Forgotten Region?]. Rofo. Fortschritte Auf Dem Gebiete Der Rontgenstrahlen und Der Neuen Bildgebenden Verfahren 1998;168:415-20.
19. Perler BA, Williams GM. Does donor iliac artery percutaneous transluminal angioplasty or stent placement influence the results of femorofemoral bypass? Analysis of 70 consecutive cases with long-term follow-up. J Vasc Surg 1996;24:363-9, 369-70.
20. Walker PJ, Harris JP, May J. Combined percutaneous transluminal angioplasty and extraanatomic bypass for symptomatic unilateral iliac artery occlusion with contralateral iliac artery stenosis. Ann Vasc Surg 1991;5:209-16,216-217.
21. Rosenbloom MS, Walsh JJ, Schuler JJ, et al. Long-term results of infragenicular bypasses with autogenous vein originating from the distal superficial femoral and popliteal arteries. J Vasc Surg 1988; 7:691-6.
22. Schweiger H, Klein P, Lang W. Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: Results of primary and secondary procedures. J Vasc Surg 1993;18: 867-74.
23. Hunink MG, Wong JB, Donaldson MC, et al. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making 1994;14:71-81.
24. Veith FJ, Gupta SK, Ascer E, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3: 104-14.
25. Ameli FM, Stein M, Aro L, et al. End-to-end versus end-to-side proximal anastomosis in aortobifemoral bypass surgery: Does it matter? Can J Surg 1991; 34:243-6.
26. Rutherford RB, Jones DN, Martin MS, et al. Serial hemodynamic assessment of aortobifemoral bypass. J Vasc Surg 1986;4:428-35.
27. Bandyk D. Appropriateness of non-invasive follow-up for vascular procedures. In: Yao J, Pierce W, editors. Practical Vascular Surgery: Appleton and Lange; 1999. p. 55-68.
28. Isakov E, Budoragin N, Shenhav S, et al. Anatomic sites of foot lesions resulting in amputation among diabetics and non-diabetics. Am J Phys Med Rehabil 1995;74:130-3.
29. Goldberg JA, Adkins P, Tsai TM. Microvascular reconstruction of the foot: Weight-bearing patterns, gait analysis, and long-term follow-up. Plast Reconstr Surg 1993;92:904-11.
30. Weinzweig N, Davies BW. Foot and ankle reconstruction using the radial forearm flap: A review of 25 cases. Plast Reconstr Surg 1998;102: 1999-2005.